webinar - streamline your sars cov 2 antibody testing with a svnt nab solution
Published 3 years ago • 55 plays • Length 1:00:18Download video MP4
Download video MP3
Similar videos
-
58:25
webinar - importance and challenge of covid-19 serology.
-
40:57
webinar - detecting neutralization antibodies to covid 19
-
1:01:40
sars-cov-2 neutralizing antibody test for evaluating neutralizing antibody prevalence in singapore
-
1:00:14
evaluate neutralization activities for covid 19 vaccine and drug development webinar
-
1:03:39
cpass™ sars cov 2 neutralizing antibody (nab) test for post vaccination monitoring
-
1:33:41
covid-19 echo session #1: troubleshooting challenges establishing diagnostic testing for sars-cov-2
-
31:21
covid-19 symposium: cellular responses to sars-cov-2 | dr. michael betts
-
1:01:26
january 2023 case conference webinar
-
1:01:52
cpass™ neutralizing antibody detection for covid-19 post vaccination monitoring
-
34:12
cpass sars-cov-2 neutralizing antibody test kit, data and applications.
-
30:46
webinar on "sars-cov-2 neutralizing antibody test"
-
48:35
enhancing strategies for covid-19 solutions in diagnosis, vaccine development and therapies
-
54:29
accelerate covid-19 antibody development via single b cell screening
-
25:49
sars-cov-2–specific b cell detection and therapeutic antibody discovery [webinar]
-
1:03:09
webinar: covid-19 & the liver: sars-cov-2 diagnostic testing and vaccine development
-
58:29
webinar: responding to emerging sars cov 2 variants
-
43:33
genscript's response to the sars cov 2 pandemic innovations in diagnostic solutions with live q&a
-
47:18
measuring levels of sars-cov-2 neutralizing antibodies in individuals using a high-throughput test
-
49:42
characterization and selection of antibodies for covid-19 diagnostics
-
21:10
webinar - covid-19: the mechanism, rate and tools for monitoring the infection
-
52:12
genscript webinar: solutions for new covid-19 variant and post-vaccination monitoring
-
32:08
us 20200930 free webinar -- rapid identification of diverse high-affinity sars-cov-2 antibodies